EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C10H13NO3 |
| Net Charge | 0 |
| Average Mass | 195.218 |
| Monoisotopic Mass | 195.08954 |
| SMILES | C[C@](N)(Cc1ccc(O)cc1)C(=O)O |
| InChI | InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1 |
| InChIKey | NHTGHBARYWONDQ-JTQLQIEISA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Role: | EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor An EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitor that interferes with the action of tyrosine 3-monooxygenase (EC 1.14.16.2). |
| Applications: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| α-methyl-L-tyrosine (CHEBI:6912) has role antihypertensive agent (CHEBI:35674) |
| α-methyl-L-tyrosine (CHEBI:6912) has role antineoplastic agent (CHEBI:35610) |
| α-methyl-L-tyrosine (CHEBI:6912) has role antipsychotic agent (CHEBI:35476) |
| α-methyl-L-tyrosine (CHEBI:6912) has role EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor (CHEBI:63932) |
| α-methyl-L-tyrosine (CHEBI:6912) is a L-tyrosine derivative (CHEBI:27177) |
| α-methyl-L-tyrosine (CHEBI:6912) is a non-proteinogenic L-α-amino acid (CHEBI:83822) |
| IUPAC Name |
|---|
| α-methyl-L-tyrosine |
| INNs | Source |
|---|---|
| metirosina | ChemIDplus |
| metirosine | KEGG DRUG |
| metirosinum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (-)-.alpha.-methyl-l-tyrosine | ChEMBL |
| (-)-alpha-Methyl-L-tyrosine | ChemIDplus |
| alpha-Methyltyrosine | ChemIDplus |
| L-588357-0 | ChEMBL |
| L-alpha-Methyltyrosine | ChemIDplus |
| L-tyrosine, .alpha.-methyl- | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 1792 | DrugCentral |
| C07921 | KEGG COMPOUND |
| D00762 | KEGG DRUG |
| DB00765 | DrugBank |
| Metirosine | Wikipedia |
| US2011104765 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:2368400 | Reaxys |
| CAS:672-87-7 | ChemIDplus |
| CAS:672-87-7 | KEGG COMPOUND |
| Citations |
|---|